Published in AIDS Weekly, September 17th, 2001
This study was conducted under an Investigational New Drug (IND) application filed with the U.S. Food and Drug Administration (FDA).
Dr. Janet Greeson, Samaritan Pharmaceuticals stated, "Achieving this milestone is significant for Samaritan. It is our hope that, after, the Aids Research Alliance (Los Angeles, California) completes the analysis of the data generated by this clinical trial, we'll be able to submit a study report to the FDA by year end (2001) or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.